Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice

Zong,Jian‑Chun; Wang,Xing; Zhou,Xiang; Wang,Chen; Chen,Liang; Yin,Liang‑Jun; He,Bai‑Cheng; Deng,Zhong‑Liang

doi:10.3892/or.2015.4430

Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice

Authors:
- Jian‑Chun Zong
- Xing Wang
- Xiang Zhou
- Chen Wang
- Liang Chen
- Liang‑Jun Yin
- Bai‑Cheng He
- Zhong‑Liang Deng
View Affiliations

Affiliations: Department of Orthopedic Surgery, The Second Affiliated Hospital, Chongqing Medical University, Yuzhong, Chongqing 400010, P.R. China, Key Laboratory for Biochemistry and Molecular Pharmacology of Chongqing Medical University, Yuzhong, Chongqing 400016, P.R. China
Published online on: November 16, 2015 https://doi.org/10.3892/or.2015.4430
Pages: 739-748

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer metastasizes to the bone in a majority of patients with advanced disease resulting in bone destruction. The underlying mechanisms are complex, and both processes are controlled by an interaction between locally and systemically derived signals. Clinically, breast cancer patients with depression have a higher risk of bone metastasis, yet the etiology and mechanisms are yet to be elucidated. MDA‑MB‑231 breast cancer cells were used to establish a bone metastasis model by using intracardiac injection in nude mice. Chronic mild stress (CMS) was chosen as a model of depression in mice before and after inoculation of the cells. Knockdown of the RUNX‑2 gene was performed by transfection of the cells with shRNA silencing vectors against human RUNX‑2. A co‑culture system was used to test the effect of the MDA‑MB‑231 cells on osteoclasts and osteoblasts. RT‑PCR and western blotting were used to test gene and protein expression, respectively. We confirmed that depression induced bone metastasis by promoting osteoclast activity while inhibiting osteoblast differentiation. Free serotonin led to an increase in the expression of RUNX2 in breast cancer cells (MDA‑MB‑231), which directly inhibited osteoblast differentiation and stimulated osteoclast differentiation by the PTHrP/RANKL pathway, which caused bone destruction and formed osteolytic bone lesions. Additionally, the interaction between depression and breast cancer cells was interrupted by LP533401 or RUNX2 knockdown. In conclusion, depression promotes breast cancer bone metastasis partly through increasing levels of gut‑derived serotonin. Activation of RUNX2 in breast cancer cells by circulating serotonin appears to dissociate coupling between osteoblasts and osteoclasts, suggesting that the suppression of gut‑derived serotonin decreases the rate of breast cancer bone metastasis induced by depression.

View Figures

View References

1	Feng X and McDonald JM: Disorders of bone remodeling. Annu Rev Pathol. 6:121–145. 2011. View Article : Google Scholar
2	Henriksen K, Bollerslev J, Everts V and Karsdal MA: Osteoclast activity and subtypes as a function of physiology and pathology - implications for future treatments of osteoporosis. Endocr Rev. 32:31–63. 2011. View Article : Google Scholar
3	Khosla S, Westendorf JJ and Oursler MJ: Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 118:421–428. 2008. View Article : Google Scholar : PubMed/NCBI
4	Novack DV and Teitelbaum SL: The osteoclast: Friend or foe? Annu Rev Pathol. 3:457–484. 2008. View Article : Google Scholar
5	Raggatt LJ and Partridge NC: Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI
6	Zaidi M: Skeletal remodeling in health and disease. Nat Med. 13:791–801. 2007. View Article : Google Scholar : PubMed/NCBI
7	Waning DL and Guise TA: Molecular mechanisms of bone metastasis and associated muscle weakness. Clin Cancer Res. 20:3071–3077. 2014. View Article : Google Scholar : PubMed/NCBI
8	Lipton A: Implications of bone metastases and the benefits of bone-targeted therapy. Semin Oncol. 37(Suppl 2): S15–S29. 2010. View Article : Google Scholar : PubMed/NCBI
9	Tonyali O, Arslan C and Altundag K: The role of zoledronic acid in the adjuvant treatment of breast cancer: Current perspectives. Expert Opin Pharmacother. 11:2715–2725. 2010. View Article : Google Scholar : PubMed/NCBI
10	Tonello L and Cocchi M: The cell membrane: Is it a bridge from psychiatry to quantum consciousness? Neuroquantology. 8:54–60. 2010. View Article : Google Scholar
11	Cocchi M and Tonello L: Bio molecular considerations in major depression and ischemic cardiovascular disease. Cent Nerv Syst Agents Med Chem. 10:97–107. 2010. View Article : Google Scholar : PubMed/NCBI
12	Cocchi M, Tonello L, De Lucia A and Amato P: Platelet and brain fatty acids: A model for the classifcation of the animals? Part 1. Int J Anthropol. 24:69–76. 2009.
13	Cocchi M, Tonello L, De Lucia A and Amato P: Platelet and brain fatty acids: A model for the classification of the animals? Part 2. Platelet and brain fatty acid transfer: Hypothesis on arachidonic acid and its relationship to major depression. Int J Anthropol. 24:201–220. 2009.
14	Heron DS, Shinitzky M, Hershkowitz M and Samuel D: Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA. 77:7463–7467. 1980. View Article : Google Scholar : PubMed/NCBI
15	Bab IA and Yirmiya R: Depression and bone mass. Ann NY Acad Sci. 1192:170–175. 2010. View Article : Google Scholar : PubMed/NCBI
16	Darmon MC, Guibert B, Leviel V, Ehret M, Maitre M and Mallet J: Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J Neurochem. 51:312–316. 1988. View Article : Google Scholar : PubMed/NCBI
17	Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H and Bader M: Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 299(76)2003. View Article : Google Scholar
18	Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, et al: Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 135:825–837. 2008. View Article : Google Scholar : PubMed/NCBI
19	Haney EM and Warden SJ: Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: Evidence from clinical studies. J Musculoskelet Neuronal Interact. 8:133–145. 2008.PubMed/NCBI
20	Rosen CJ: Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 7:7–10. 2008. View Article : Google Scholar : PubMed/NCBI
21	Kopparapu PK, Tinzl M, Anagnostaki L, Persson JL and Dizeyi N: Expression and localization of serotonin receptors in human breast cancer. Anticancer Res. 33:363–370. 2013.PubMed/NCBI
22	Hernandez LL, Gregerson KA and Horseman ND: Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am J Physiol Endocrinol Metab. 302:E1009–E1015. 2012. View Article : Google Scholar : PubMed/NCBI
23	Horseman ND and Hernandez LL: New concepts of breast cell communication to bone. Trends Endocrinol Metab. 25:34–41. 2014. View Article : Google Scholar
24	Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR and Sterling JA: TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res. 71:822–831. 2011. View Article : Google Scholar :
25	Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T and Mundy GR: Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 98:1544–1549. 1996. View Article : Google Scholar : PubMed/NCBI
26	Liu R, Dang W, Jianting M, Su C, Wang H, Chen Y and Tan Q: Citalopram alleviates chronic stress induced depression-like behaviors in rats by activating GSK3β signaling in dorsal hippo-campus. Brain Res. 1467:10–17. 2012. View Article : Google Scholar : PubMed/NCBI
27	Zhao Y, Wang Z, Dai J, Chen L, Huang Y and Zhan Z: Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice. Behav Brain Res. 228:339–350. 2012. View Article : Google Scholar
28	Conway CC, Hammen C, Brennan PA, Lind PA and Najman JM: Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression. Depress Anxiety. 27:737–745. 2010.PubMed/NCBI
29	Liu Q, Yang Q, Sun W, Vogel P, Heydorn W, Yu XQ, Hu Z, Yu W, Jonas B, Pineda R, et al: Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J Pharmacol Exp Ther. 325:47–55. 2008. View Article : Google Scholar : PubMed/NCBI
30	Satin JR, Linden W and Phillips MJ: Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer. 115:5349–5361. 2009. View Article : Google Scholar : PubMed/NCBI
31	Pinquart M and Duberstein PR: Depression and cancer mortality: A meta-analysis. Psychol Med. 40:1797–1810. 2010. View Article : Google Scholar : PubMed/NCBI
32	Vodermaier A, Linden W, Rnic K, Young SN, Ng A, Ditsch N and Olson R: Prospective associations of depression with survival: A population-based cohort study in patients with newly diagnosed breast cancer. Breast Cancer Res Treat. 143:373–384. 2014. View Article : Google Scholar :
33	Yirmiya R and Bab I: Major depression is a risk factor for low bone mineral density: A meta-analysis. Biol Psychiatry. 66:423–432. 2009. View Article : Google Scholar : PubMed/NCBI
34	Yadav VK and Ducy P: Lrp5 and bone formation: A serotonin-dependent pathway. Ann NY Acad Sci. 1192:103–109. 2010. View Article : Google Scholar
35	Kode A, Mosialou I, Silva BC, Rached MT, Zhou B, Wang J, Townes TM, Hen R, DePinho RA, Guo XE, et al: FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin. J Clin Invest. 122:3490–3503. 2012. View Article : Google Scholar : PubMed/NCBI
36	Rucci N and Teti A: Osteomimicry: How tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2:907–915. 2010. View Article : Google Scholar
37	Standal T, Borset M and Sundan A: Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol. 26:179–184. 2004.PubMed/NCBI
38	Marie PJ: Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys. 473:98–105. 2008. View Article : Google Scholar : PubMed/NCBI
39	Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
40	Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS and Lian JB: Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem. 66:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
41	Mendoza-Villanueva D, Zeef L and Shore P: Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res. 13:R1062011. View Article : Google Scholar
42	Pratap J, Wixted JJ, Gaur T, Zaidi SK, Dobson J, Gokul KD, Hussain S, van Wijnen AJ, Stein JL, Stein GS, et al: Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 68:7795–7802. 2008. View Article : Google Scholar : PubMed/NCBI
43	Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB and Stein GS: Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA. 102:1454–1459. 2005. View Article : Google Scholar : PubMed/NCBI
44	Karaplis AC and Goltzman D: PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord. 1:331–341. 2000. View Article : Google Scholar
45	Kozlow W and Guise TA: Breast cancer metastasis to bone: Mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 10:169–180. 2005. View Article : Google Scholar : PubMed/NCBI
46	Mundy GR: Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2:584–593. 2002. View Article : Google Scholar : PubMed/NCBI
47	Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS and Lian JB: The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol. 25:8581–8591. 2005. View Article : Google Scholar : PubMed/NCBI